Skip to content

Author

Y. Ling

We have 3 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Association of Life’s Essential 8 and its components with adverse cardiovascular and kidney events in patients with atherosclerotic cardiovascular disease: a prospective cohort study

Optimal Life’s Essential 8 cardiovascular health is associated with lower risk of MACEs and CKD progression in ASCVD patients, with smoking and glucose as primary modifiable drivers of residual risk for MACEs, and glucose, BMI and smoking for CKD.

Z. Yuan, X. Lu, G. Yuan et al. · 0 citations
Open access Oct 2026

Association of Lipoprotein(a) with cardiovascular and all-cause mortality in China: a cohort study based on cardiorenal improvementNT-II

Lipoprotein(a) [Lp(a)] is a well-recognized hazard indicator for cardiovascular disease (CVD) and all-cause mortality. Higher Lp(a) levels are robustly correlated with adverse cardiovascular outcomes. However, Lp(a) exhibits notable ethnic heterogeneities, with most epidemiological studies conducted primarily in...

G. Yuan, X. Lu, Z. Yuan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.